Status:

COMPLETED

CHASE : aCcelerated 23-Hour erAS Care for Colorectal Surgery

Lead Sponsor:

Zuyderland Medisch Centrum

Conditions:

Colorectal Cancer

Enhanced Recovery After Surgery

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

Rationale: Throughout the years, there has been a rapid change in the perioperative protocols and procedures surrounding colorectal surgery. Upon the introduction of the Enhanced Recovery After Surger...

Detailed Description

The aim of this study is to investigate the feasibility and safety of a 23-hour accelerated ERAS 2.0 protocol for patients undergoing colorectal surgery compared to a retrospective cohort of patients ...

Eligibility Criteria

Inclusion

  • Signed informed consent;
  • Is ≥ 18 years ≤ 80;
  • BMI ≤ 35 kg/m2;
  • WHO performance status = 0
  • Is diagnosed with (non-complicated) colorectal cancer
  • Is scheduled to undergo elective laparoscopic colorectal surgery (ileocecal resection, right or left hemicolectomy, transvers colon resection) with primary anastomosis;
  • Primary anastomosis is performed intracorporeally;
  • Uncomplicated operation;
  • Readily available ambulant care provided by an adult family member for the first 24 hours after discharge;
  • Patient is adequately reachable by phone.

Exclusion

  • ASA classification ≥ 3;
  • Subjects who have limited mobility and/or need to be aided/assisted when mobilizing;
  • Subjects with a history of active pulmonary infection, any other active infection, any uncontrolled medical disease
  • Subjects with a contraindication for oral NSAIDs;
  • Subjects with a contraindication for spinal anesthesia;
  • Subjects requiring parenteral nutrition prior to surgery;
  • Subjects scheduled to undergo lower rectal resections;
  • Subjects receiving an ostomy;
  • Subjects who experience complications preoperatively;
  • Subjects who are mentally incompetent, challenged or requiring aid with daily life activities.

Key Trial Info

Start Date :

June 19 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 30 2021

Estimated Enrollment :

41 Patients enrolled

Trial Details

Trial ID

NCT04461275

Start Date

June 19 2020

End Date

September 30 2021

Last Update

March 2 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Zuyderland Medical Center

Sittard, Limburg, Netherlands, 6162 BG